Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Soliris
Pharma
Health plan sues AZ's Alexion over 'fraudulent' Soliris patents
Nonprofit health plan EmblemHealth claims that AstraZeneca's Alexion unit fraudulently won extra patents on rare disease blockbuster Soliris.
Zoey Becker
Apr 17, 2025 10:50am
A closer look at pharma’s top patent losses in 2025
Mar 21, 2025 9:00am
The top 10 drugs losing US exclusivity in 2025
Mar 17, 2025 3:00am
AZ’s Alexion creates interactive storybook for kids with aHUS
Feb 12, 2025 12:00pm
With biosim sales up 16%, Amgen expects another boost in 2025
Feb 5, 2025 11:28am
Argenx's Vyvgart holds its own against AZ's rare disease duo
Jul 25, 2024 3:16pm
